Malvern's Baudax Bio plans $12 million stock offering

Malvern's Baudax Bio plans $12 million stock offering

bizjournals

Published

A Chester County biopharmaceutical company expects to raise $12 million in a direct stock offering set to close later this week. Baudax Bio (NASDAQ: BXRX) of Malvern said Monday it has entered into a definitive agreement with a healthcare-focused institutional investor, whose identity the company declined to disclose, for the purchase and sale of more than 10.1 million shares of common stock — and an additional number of warrants to purchase additional shares. The common stock is priced at $1.185…

Full Article